Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zhejiang Nhu Co's share price for the quarter that ended in Jun. 2026 was ¥28.42. Zhejiang Nhu Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 3,073 Mil. Therefore, Zhejiang Nhu Co's market cap for the quarter that ended in Jun. 2026 was ¥87,347 Mil.
Zhejiang Nhu Co's quarterly market cap
increased
from Dec. 2025 (¥77,420 Mil) to Mar. 2026 (¥106,187 Mil) but then
declined
from Mar. 2026 (¥106,187 Mil) to Jun. 2026 (¥87,347 Mil).
Zhejiang Nhu Co's annual market cap
increased
from Dec. 2023 (¥52,422 Mil) to Dec. 2024 (¥67,523 Mil) and
increased
from Dec. 2024 (¥67,523 Mil) to Dec. 2025 (¥77,420 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zhejiang Nhu Co's Enterprise Value for Today is ¥78,407 Mil.
Zhejiang Nhu Co (SZSE:002001) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Zhejiang Nhu Co Market Cap Related Terms
Zhejiang Nhu Co Market Cap Historical Data
* Premium members only.
The historical data trend for Zhejiang Nhu Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Nhu Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Zhejiang Nhu Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Zhejiang Nhu Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Nhu Co (SZSE:002001) has a Market Cap of ¥81,415 Mil as of Sep. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zhejiang Nhu Co and its competitors. According to the industry distribution chart, Zhejiang Nhu Co ranks #45 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 4.4%.
Is Zhejiang Nhu Co's Market Cap too high?
Zhejiang Nhu Co's current Market Cap is ¥81,415 Mil. Based on the distribution chart, Zhejiang Nhu Co ranks #45 out of 1024 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Nhu Co has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Nhu Co's Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Nhu Co ranks #45 out of 1024 companies for Market Cap. This places Zhejiang Nhu Co in the top 4% of its industry — outperforming the majority of peers. The industry median Market Cap is 239.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 239.19, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zhejiang Nhu Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 239.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Nhu Co's current Market Cap is ¥81,415 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Nhu Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Nhu Co (SZSE:002001) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.59, compared to a current price of ¥26.49 — trading 7.3% below its estimated fair value. The current Market Cap is ¥81,415 Mil. Zhejiang Nhu Co's overall GF Score™ is 98/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Zhejiang Nhu Co (SZSE:002001), the current Market Cap is ¥81,415 Mil as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Nhu Co (SZSE:002001) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Nhu Co stock appears to be undervalued.
The current stock price of ¥26.49 is trading 7.3% below its estimated GF Value™ of ¥28.59.
GuruFocus considers Zhejiang Nhu Co to be Fairly Valued.
Key valuation signals for SZSE:002001:
Market Cap: ¥81,415 Mil
GF Value™: ¥28.59 vs. price of ¥26.49 (7.3% below fair value)
No single metric tells the full story. See the SZSE:002001 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives, and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer, and Anti-bacterial, with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3, and coenzyme Q10, and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
98GF Score
Get the complete analysis for SZSE:002001
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002001 has been successfully added to your 
